🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Tig Advisors - Q4 2023 13F Filings

TI

Tig Advisors, LLC

CIK: 0001358253
Address: New York New York C/O Alti Global, Inc. 22 Vanderbilt Avenue, 27Th Floor
$801.08 M
Portfolio Value
48
Assets Held
Reporting Period: Q4 2023
Filing Status:
Active
Last Updated: 02/17/2026

Portfolio Summary (Q4 2023)

View Full Portfolio Analysis

Top Buys

Q4 2023
1. Immunogen
+$68.6 M
2. Pioneer Nat Res Co
+$49.35 M
+$38.98 M

Top Sells

Q4 2023
2. Vmware
−$286.69 M
3. Horizon Therapeutics PLC
−$281.02 M
4. Seagen
−$240.68 M
5. National Instrs
−$181.21 M

Asset Allocation

Stocks/ETFs
-66.59%
$644.26 M 80.42%
Options
-29.36%
$134.25 M 16.76%
Debt
$0 0.00%
Other
-77.65%
$22.58 M 2.82%

Sector Allocation (Stocks)

Tig Advisors Q4 2023 Filing Summary

Tig Advisors, LLC filed its 13F report for Q4 2023 on February 14, 2024. The portfolio totaled 801.08 M reflecting a -63.91% change from the prior quarter, spanning 48 assets. Allocations were 80.4% Equities, 16.8% Options, and 0.0% Debt. The top 10 holdings comprised 92.5% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 16 new positions and 26 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Tig Advisors’s Q4 2023 Filing

Tig Advisors submitted their Form 13F-HR for the Q4 2023 period on 02/14/2024. This was the only submission for the quarter.

In the Q4 2023 filing, Tig Advisors reported a managed portfolio value of 801.08 M, consisting of 48 individual positions.

This page displays the raw filing documents. To see which stocks Tig Advisors bought or sold during Q4 2023, please visit Tig Advisors's Portfolio Analysis page.